Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the target of a significant decline in short interest in February. As of February 13th, there was short interest totaling 1,939 shares, a decline of 26.5% from the January 29th total of 2,638 shares. Based on an average trading volume of 7,528 shares, the short-interest ratio is currently 0.3 days. Based on an average trading volume of 7,528 shares, the short-interest ratio is currently 0.3 days.
Hikma Pharmaceuticals Price Performance
Shares of HKMPY opened at $33.11 on Wednesday. The business’s 50 day moving average is $42.14 and its 200 day moving average is $44.16. Hikma Pharmaceuticals has a 12-month low of $33.07 and a 12-month high of $56.94.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- New Copper-Rich “Kraken” Zone Discovered
- Elon Warns “America Is Broke”. Trump’s Plan Inside.
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
